Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

CDMO leader Marc Funk will succeed Ridinger as CEO of Lonza.

Lonza Names New CEO

Fujifilm increases capacity of its Bio-CDMO business with an expansion of production in North Carolina.

Fujifilm Invests in Biopharmaceutical Production Capacity

The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.

Cambrex Acquires Avista Pharma

Birte Kleindienst is junior product manager, viral clearance, at Sartorius Stedim Biotech.

Anika Manzke is product manager, viral clearance at Sartorius Stedim Biotech.

Peter Kosiol is scientist, Membrane Development atSartorius Stedim Biotech

Requirements for virus filtration must be considered in developing continuous downstream processes. 

Continuous Processing: Challenges and Opportunities of Virus Filtration

Ronald A. Rader is senior director, Technical Research, at BioPlan Associates.

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Outsourcing of manufacturing activities is expected to increase in 2019.

The Outlook for CMO Outsourcing in 2019

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

While pharma is proving its capabilities to develop novel therapies, the industry still needs to work on manufacturing innovation.

Bio/Pharma Needs Ideas and Incentives to Advance Manufacturing

Keeping valuable employees happy-and on the job-may test bio/pharma business decisions.

Solving Bio/Pharma Employee Career Advancement Demands

Intellectual challenge, work/life balance, compensation, and an unclear business outlook create uncertainty among European bio/pharma employees.

Apprehension Shapes Employee Satisfaction

The company is investing approximately $14 million to expand biologics packaging capabilities and capacity at its biologics manufacturing facility in Bloomington, IN.

Catalent Expands Biologics Packaging Capabilities at Indiana Site

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

CMOs and CDMOs made investments in new and expanded facilities and services in the last quarter of 2018.